1. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome;Choi, Y.; Lafferty, J.A.; Clements, JR;J Exp Med,1990
2. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome;Curtis, N.; Chan, B.; Levin, M.;Lancet,1994
3. Severity of cystic fibrosis in patients homozygous and heterozygous for AF508 mutation;Johansen, H.K.; Nir, M.; Hoiby, N.; Koch, C.; Schwatz, M.;Lancet,1991
4. Cystic fibrosis: the AF508 mutation does not lead to an exceptionally severe phenotype. A cohort study;Borgo, G.; Gasparini, P.; Bonizzato, A.; Cabrini, G.; Mastella, G.; Pignatti, P.F.;Eur J Pediatr,1993
5. Pseudomonas cepacia colonization among patients with cystic fibrosis;Thomassen, M.J.; Demko, C.A.; Klinger, J.D.; Stern, R.C.;Am Rev Respir Dis,1985